VITIELLO, MARIANNA
VITIELLO, MARIANNA
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells
2023 Barresi, Elisabetta; Baldanzi, Caterina; Roncetti, Marta; Roggia, Michele; Baglini, Emma; Lepori, Irene; Vitiello, Marianna; Salerno, Silvia; Tedeschi, Lorena; Da Settimo, Federico; Cosconati, Sandro; Poliseno, Laura; Taliani, Sabrina
An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22
2022 Centomo, Maria Laura; Vitiello, Marianna; Poliseno, Laura; Pandolfi, Pier Paolo
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
2021 Vitiello, Marianna; Kusmic, Claudia; Faita, Francesco; Poliseno, Laura
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma
2019 Vitiello, M; Evangelista, M; Di Lascio, N; Kusmic, C; Massa, A; Orso, F; Sarti, S; Marranci, A; Rodzik, K; Germelli, L; Chandra, D; Salvetti, A; Pucci, A; Taverna, D; Faita, F; Gravekamp, C; Poliseno, L
Biological role of miR-204 and miR-211 in melanoma
2018 D'Aurizio, Romina; Vitiello, Marianna; Poliseno, Laura
Context-dependent miR-204 and miR-211 differentially affect the biological properties of amelanotic and melanotic melanoma cells
2017 Vitiello, M; Tuccoli, A; D'Aurizio, R; Sarti, S; Giannecchini, L; Lubrano, S; Marranci, A; Evangelista, M; Peppicelli, S; Ippolito, C; Barravecchia, I; Guzzolino, E; Montagnani, V; Gowen, M; Mercoledi, E; Mercatanti, A; Comelli, L; Gurrieri, S; Wu, Lw; Ope, O; Flaherty, K; Boland, Gm; Hammond, Mr; Kwong, L; Chiariello, M; Stecca, B; Zhang, G; Salvetti, A; Angeloni, D; Pitto, L; Calorini, L; Chiorino, G; Pellegrini, M; Herlyn, M; Osman, I Poliseno L
CRISPR/Cas Technologies Applied to Pseudogenes
2021 Vitiello, Marianna; Poliseno, Laura
GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma
2021 Scatolini, M.; Patel, A.; Grosso, E.; MelloGrand, M.; Ostano, P.; Coppo, R.; Vitiello, M.; Venesio, T.; Zaccagna, A.; Pisacane, A.; Sarotto, I; Taverna, D.; Poliseno, L.; Bergamaschi, D.; Chiorino, G.
Identification of BRAF 3'UTR Isoforms in Melanoma
2015 Marranci, A; Tuccoli, A; Vitiello, M; Mercoledi, E; Sarti, S; Lubrano, S; Evangelista, M; Fogli, A; Valdes, C; Russo, F; Monte, Md; A Caligo, M; Pellegrini, M; Capobianco, E; Tsinoremas, N; Poliseno, L
In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System
2021 Vitiello, Marianna; Poliseno, Laura; Pandolfi Pier, Paolo
Long non-coding RNAs in cancer: implications for personalized therapy
2015 Vitiello, Marianna; Tuccoli, Andrea; Poliseno, Laura
Methods for the Identification of PTEN-Targeting MicroRNAs
2016 Tuccoli, A; Vitiello, M; Marranci, A; Russo, F; Poliseno, L
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response
2019 Barravecchia, Ivana; Mariotti, Sara; Pucci, Angela; Scebba, Francesca; De Cesari, Chiara; Bicciato, Silvio; Tagliafico, Enrico; Tenedini, Elena; Vindigni, Carla; Cecchini, Marco; Berti, Gabriele; Vitiello, Marianna; Poliseno, Laura; Mazzanti Chiara, Maria; Angeloni, Debora
PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation
2023 Marranci, A; Prantera, A; Masotti, S; De Paolo, R; Baldanzi, C; Podda, Ms; Mero, S; Vitiello, M; Franchin, C; Laezza, M; Comelli, L; Arrigoni, G; Cervelli, T; Del Pozzo, G; Poliseno, L
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System
2021 Corrado, Alda; Aceto, Romina; Silvestri, Roberto; Dell'Anno, Irene; Ricci, Benedetta; Miglietta, Simona; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Garritano, Sonia; Giusti, Laura; Zallocco, Lorenzo; Elisei, Rossella; Landi, Stefano; Gemignani, Federica
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model
2020 Finamore, Francesco; Ucciferri, Nadia; Signore, Giovanni; Cecchettini, Antonella; Ceccherini, Elisa; Vitiello, Marianna; Poliseno, Laura; Rocchiccioli, Silvia
PTENP1 is a ceRNA for PTEN: it's CRISPR clear
2020 Vitiello M.; Evangelista M.; Zhang Y.; Salmena L.; Pandolfi P.P.; Poliseno L.
The landscape of BRAF transcript and protein variants in human cancer
2017 Marranci, A; Jiang, Z; Vitiello, M; Guzzolino, E; Comelli, L; Sarti, S; Lubrano, S; Franchin, C; Echevarriavargas, I; Tuccoli, A; Mercatanti, A; Evangelista, M; Sportoletti, P; Cozza, G; Luzi, E; Capobianco, E; Villanueva, J; Arrigoni, G; Signore, G; Rocchiccioli, S; Pitto, L; Tsinoremas, N; Poliseno, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells | 1-gen-2023 | Barresi, Elisabetta; Baldanzi, Caterina; Roncetti, Marta; Roggia, Michele; Baglini, Emma; Lepori, Irene; Vitiello, Marianna; Salerno, Silvia; Tedeschi, Lorena; Da Settimo, Federico; Cosconati, Sandro; Poliseno, Laura; Taliani, Sabrina | |
| An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22 | 1-gen-2022 | Centomo, Maria Laura; Vitiello, Marianna; Poliseno, Laura; Pandolfi, Pier Paolo | |
| Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma | 1-gen-2021 | Vitiello, Marianna; Kusmic, Claudia; Faita, Francesco; Poliseno, Laura | |
| Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma | 1-gen-2019 | Vitiello, M; Evangelista, M; Di Lascio, N; Kusmic, C; Massa, A; Orso, F; Sarti, S; Marranci, A; Rodzik, K; Germelli, L; Chandra, D; Salvetti, A; Pucci, A; Taverna, D; Faita, F; Gravekamp, C; Poliseno, L | |
| Biological role of miR-204 and miR-211 in melanoma | 1-gen-2018 | D'Aurizio, Romina; Vitiello, Marianna; Poliseno, Laura | |
| Context-dependent miR-204 and miR-211 differentially affect the biological properties of amelanotic and melanotic melanoma cells | 1-gen-2017 | Vitiello, M; Tuccoli, A; D'Aurizio, R; Sarti, S; Giannecchini, L; Lubrano, S; Marranci, A; Evangelista, M; Peppicelli, S; Ippolito, C; Barravecchia, I; Guzzolino, E; Montagnani, V; Gowen, M; Mercoledi, E; Mercatanti, A; Comelli, L; Gurrieri, S; Wu, Lw; Ope, O; Flaherty, K; Boland, Gm; Hammond, Mr; Kwong, L; Chiariello, M; Stecca, B; Zhang, G; Salvetti, A; Angeloni, D; Pitto, L; Calorini, L; Chiorino, G; Pellegrini, M; Herlyn, M; Osman, I Poliseno L | |
| CRISPR/Cas Technologies Applied to Pseudogenes | 1-gen-2021 | Vitiello, Marianna; Poliseno, Laura | |
| GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma | 1-gen-2021 | Scatolini, M.; Patel, A.; Grosso, E.; MelloGrand, M.; Ostano, P.; Coppo, R.; Vitiello, M.; Venesio, T.; Zaccagna, A.; Pisacane, A.; Sarotto, I; Taverna, D.; Poliseno, L.; Bergamaschi, D.; Chiorino, G. | |
| Identification of BRAF 3'UTR Isoforms in Melanoma | 1-gen-2015 | Marranci, A; Tuccoli, A; Vitiello, M; Mercoledi, E; Sarti, S; Lubrano, S; Evangelista, M; Fogli, A; Valdes, C; Russo, F; Monte, Md; A Caligo, M; Pellegrini, M; Capobianco, E; Tsinoremas, N; Poliseno, L | |
| In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System | 1-gen-2021 | Vitiello, Marianna; Poliseno, Laura; Pandolfi Pier, Paolo | |
| Long non-coding RNAs in cancer: implications for personalized therapy | 1-gen-2015 | Vitiello, Marianna; Tuccoli, Andrea; Poliseno, Laura | |
| Methods for the Identification of PTEN-Targeting MicroRNAs | 1-gen-2016 | Tuccoli, A; Vitiello, M; Marranci, A; Russo, F; Poliseno, L | |
| MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response | 1-gen-2019 | Barravecchia, Ivana; Mariotti, Sara; Pucci, Angela; Scebba, Francesca; De Cesari, Chiara; Bicciato, Silvio; Tagliafico, Enrico; Tenedini, Elena; Vindigni, Carla; Cecchini, Marco; Berti, Gabriele; Vitiello, Marianna; Poliseno, Laura; Mazzanti Chiara, Maria; Angeloni, Debora | |
| PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation | 1-gen-2023 | Marranci, A; Prantera, A; Masotti, S; De Paolo, R; Baldanzi, C; Podda, Ms; Mero, S; Vitiello, M; Franchin, C; Laezza, M; Comelli, L; Arrigoni, G; Cervelli, T; Del Pozzo, G; Poliseno, L | |
| Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System | 1-gen-2021 | Corrado, Alda; Aceto, Romina; Silvestri, Roberto; Dell'Anno, Irene; Ricci, Benedetta; Miglietta, Simona; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Garritano, Sonia; Giusti, Laura; Zallocco, Lorenzo; Elisei, Rossella; Landi, Stefano; Gemignani, Federica | |
| Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model | 1-gen-2020 | Finamore, Francesco; Ucciferri, Nadia; Signore, Giovanni; Cecchettini, Antonella; Ceccherini, Elisa; Vitiello, Marianna; Poliseno, Laura; Rocchiccioli, Silvia | |
| PTENP1 is a ceRNA for PTEN: it's CRISPR clear | 1-gen-2020 | Vitiello M.; Evangelista M.; Zhang Y.; Salmena L.; Pandolfi P.P.; Poliseno L. | |
| The landscape of BRAF transcript and protein variants in human cancer | 1-gen-2017 | Marranci, A; Jiang, Z; Vitiello, M; Guzzolino, E; Comelli, L; Sarti, S; Lubrano, S; Franchin, C; Echevarriavargas, I; Tuccoli, A; Mercatanti, A; Evangelista, M; Sportoletti, P; Cozza, G; Luzi, E; Capobianco, E; Villanueva, J; Arrigoni, G; Signore, G; Rocchiccioli, S; Pitto, L; Tsinoremas, N; Poliseno, L |